Armata Pharmaceuticals, Inc. (ARMP) Earnings History
Annual and quarterly earnings data from 1993 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | -565.4% | -820.2% | -365.6% |
| 2023 | 78.5% | -902.8% | -1524.5% |
| 2022 | -535.7% | -670.8% | -670.2% |
| 2021 | -347.4% | -532.5% | -517.5% |
| 2020 | -1655.0% | -2623.0% | -2695.1% |
Download Data
Export ARMP earnings history in CSV or JSON format
Free sign-in required to download data
Armata Pharmaceuticals, Inc. (ARMP) Earnings Overview
As of March 4, 2026, Armata Pharmaceuticals, Inc. (ARMP) reported trailing twelve-month net income of -$47M, reflecting +0.7% year-over-year growth. The company earned $-1.29 per diluted share over the past four quarters, with a net profit margin of -3.7%.
Looking at the long-term picture, ARMP's historical earnings data spans multiple years. The company achieved its highest annual net income of $23M in fiscal 2014.
Armata Pharmaceuticals, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including MCRB ($5M net income), PHGE (-$37M net income), EVGN (-$3M net income, -1.9% margin), ARMP has comparable earnings metrics. Compare ARMP vs MCRB →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
29 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$19M | +72.6% | -$42M | $-0.52 | -365.6% | -820.2% |
| 2023 | -$69M | -87.0% | -$41M | $-1.91 | -1524.5% | -902.8% |
| 2022 | -$37M | -59.4% | -$37M | $-1.08 | -670.2% | -670.8% |
| 2021 | -$23M | -4.4% | -$24M | $-0.96 | -517.5% | -532.5% |
| 2020 | -$22M | -13.9% | -$22M | $-1.35 | -2695.1% | -2623.0% |
| 2019 | -$19M | -60.9% | -$19M | $-2.43 | - | - |
| 2018 | -$12M | +5.7% | -$13M | $-8.90 | - | - |
| 2017 | -$13M | +31.9% | -$16M | $-27.34 | -11163.5% | -14048.7% |
| 2016 | -$19M | -3550.8% | -$23M | $-345.80 | -7245.4% | -8991.5% |
| 2015 | $-516,000 | -102.2% | -$10M | $-278.60 | -108.6% | -2153.1% |
See ARMP's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ARMP Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ARMP vs AGIO
See how ARMP stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is ARMP growing earnings?
ARMP EPS of $-1.29 reflects slowing growth at +0.7%, below the 5-year CAGR of N/A. TTM net income is $-47M. Expansion rate has moderated.
What are ARMP's profit margins?
Armata Pharmaceuticals, Inc. net margin is -3.7%, with operating margin at -8.2%. Below-average margins reflect competitive or cost pressures.
How consistent are ARMP's earnings?
ARMP earnings data spans 1993-2024. The current earnings trend is +0.7% YoY. Historical data enables comparison across business cycles.